Potentials and limitations of microorganisms as renal failure biotherapeutics

References

• CharlesSDavidMStaciaMControl of body fluid, electrolyte, and acid-base balanceHuman Physiology: Foundations and FrontiersSt Louis, MOTimes-Mirror College Publications1998526527
   Google Scholar
• AshabaHBergstromJFurstChristina JYahielVMiddle molecules in uremia and other diseases1980137141
   Google Scholar
• CohenBDKulteRGeoffreyBBenjaminBCUremic toxins in uremiaInternational Conference on Pathogenesis, Diagnosis and Therapy1972111
   Google Scholar
• KolffWJArtificial kidney and artificial heart: further considerationsInt J Artif Organs19901374044062401576
   PubMed Web of Science ®Google Scholar
• EspositoRCarmeloGSorbents and their clinical applicationsLondon, UKAcademic Press1980133153
   Google Scholar
• KjellstrandCBorgesHPruCGardnerDFinkDOn the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremiaTrans Am Soc Artif Intern Organs19812724307036498
   PubMedGoogle Scholar
• PrakashSOral bacteriology compositions and methodsWashington, DCUS Government Patent #70261602006
   Google Scholar
• CastelmanBMcNeelyBUCase records of the Massachusetts General HospitalN Engl J Med1974290139494808500
   PubMedGoogle Scholar
• CattaneoMVChangTMThe potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremiaASAIO Trans199137280871649615
   PubMedGoogle Scholar
• ChangTMSemipermeable aqueous microcapsules (“artificial cells”): with emphasis on experiments in an extracorporeal shunt systemTrans Am Soc Artif Intern Organs19661213195960694
   PubMedGoogle Scholar
• ChangTMSemipermeable microcapsulesScience196414652452514190240
   PubMed Web of Science ®Google Scholar
• ChangTMBiotechnological and medical applications based on immobilization of hepatocytes, microorganisms, or enzyme systems by microencapsulation in artificial cellsAnn N Y Acad Sci19906131091152075970
   PubMed Web of Science ®Google Scholar
• ChangTMSBiotechnology of artificial cells including its application in artificial organsThe Principles, Applications and Regulations of Biotechnology in Industry, Agriculture and MedicineNew York, NYPergamon Press19855372
   Google Scholar
• ChangTMSArtificial cells for artificial kidney, artificial liver and detoxificationArtificial Kidney, Artificial Liver and Artificial CellsNew York, NYPlenum Press19785777
   Google Scholar
• ChangTMSMaloufCRessurreccionEArtificial cells containing multienzyme systems for the sequential conversion of urea into ammonia, glutamate, then alanineArtif Organs19793Suppl284287
   Google Scholar
• SparksREReview of gastrointestinal perfusion in the treatment of uremiaClin Nephrol19791128185378490
   PubMed Web of Science ®Google Scholar
• ChangTMMedical applications of immobilized proteins, enzymes, and cellsMethods Enzymol19881374444573374352
   PubMed Web of Science ®Google Scholar
• ChangTMSNew approaches using immobilized enzymes for the removal of urea and ammoniaEnzyme Eng19805225229
   Google Scholar
• GuKFChangTMConversion of alpha-ketoglutarate into L-glutamic acid with urea as ammonium source using multienzyme systems and dextran-NAD(+) immobilized by microencapsulation within artificial cells in a bioreactorBiotechnol Bioeng198832336336818584759
   PubMed Web of Science ®Google Scholar
• KolffWJLongitudinal perspectives on sorbents in uremiaKidney Int Suppl19767S2112141070535
   PubMed Web of Science ®Google Scholar
• SanakaTSuginoNTeraokaSOtaKTherapeutic effects of oral sorbent in undialyzed uremiaAm J Kidney Dis1988122971033400639
   PubMed Web of Science ®Google Scholar
• SparksREMasonNSMeierPMSamuelsWELittMHLindanOBinders to remove uremic waste metabolites from the GI tractTrans Am Soc Artif Intern Organs1972184584644844679903
   PubMedGoogle Scholar
• WalkerJMJacobsonRLStephenWJRoseDThe Role of Adsorbents in the Wearable Artificial KidneyLondon, UKMacMillan Press1977137149
   Google Scholar
• FriedmanEABowel as a kidney substitute in renal failureAm J Kidney Dis19962869439508957051
   PubMed Web of Science ®Google Scholar
• WolfeEAChangTMOrally ingested microencapsulated urease and an adsorbent, zirconium phosphate, to remove urea in kidney failureInt J Artif Organs19871042692743666978
   PubMed Web of Science ®Google Scholar
• Gruy-KapralCEmmettMSanta AnaCAPorterJLFordtranJSFineKDEffect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal diseaseJ Am Soc Nephrol1998910192419309773794
   PubMed Web of Science ®Google Scholar
• GardnerDLKjellstrandCMHasslerCRFinkDJEmmerlingDCAn orally administered microcapsule system for treating chronic renal failure patientsAppl Biochem Biotechnol19841027406524933
   PubMed Web of Science ®Google Scholar
• GuKFChangTMConversion of ammonia or urea into essential amino acids, L-leucine, L-valine, and L-isoleucine, using artificial cells containing an immobilized multienzyme system and dextran-NAD+ 2. Yeast alcohol dehydrogenase for coenzyme recyclingBiotechnol Appl Biochem19901232272361694439
   PubMed Web of Science ®Google Scholar
• HughesRWilliamsRClinical experience with charcoal and resin hemoperfusionSemin Liver Dis19811691727347021
   PubMedGoogle Scholar
• ManNKDruekeTBeckerAZingraffJJungersPFunck-BrentanoJLClinical use of oxystarchKidney Int Suppl19767S2692721070545
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMPreparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removalBiotechnol Bioeng199546662162618623357
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMMicroencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic ratsNat Med1996288838878705857
   PubMed Web of Science ®Google Scholar
• HumesHDTissue engineering of the kidneyThe Biomedical Engineering HandbookBaton Rouge, FLCRC Press199518071824
   Google Scholar
• MooneyhanCSomething fishy in human blood could save lives2007Accessed on Mar 10, 2009 Available from: http://www.fasebj.org/Press_Room/April_07_2_Press_Release.pdf
   Google Scholar
• ChangTMArtificial cells and bioencapsulation in bioartificial organsAnn N Y Acad Sci19978312492599616717
   PubMed Web of Science ®Google Scholar
• SetalaKHeinonenHSchreck-PurlaIIngestion of lyophilized soil bacteria for alleviation of uremic symptomsJ Inst Res Comm Syst197373
   Google Scholar
• SchloerbPRThe management of uremia by perfusion of an isolated jejunal segment: with observations of the dynamics of water and electrolyte exchange in the human jejunumJ Clin Invest195837121818183513611050
   PubMed Web of Science ®Google Scholar
• ChangTMRemoval of endogenous and exogenous toxins by a microencapsulated absorbentCan J Physiol Pharmacol19694712104310455360363
   PubMed Web of Science ®Google Scholar
• ChangTMSArtificial CellsSpringfield, ILThomas1972
   Google Scholar
• JuggiJSExtracorporeal cation-exchange circuits in the treatment of hyperammonaemia of hepatic failureMed J Aust19731199269304715399
   PubMed Web of Science ®Google Scholar
• GiordanoCEspositoRPluvioMFurther studies with oxystarchKidney Int Suppl19767S2662681070544
   PubMed Web of Science ®Google Scholar
• SetalaKHeinonenHSchreck-PurolaIUraemic waste recovery. II. In vitro studiesProc Eur Dial Transplant Assoc197295145204668924
   PubMedGoogle Scholar
• ChangTMArtificial cells: 35 yearsArtif Organs19921618121338616
   PubMed Web of Science ®Google Scholar
• BruniSChangTMEncapsulated hepatocytes for controlling hyperbilirubinemia in Gunn ratsInt J Artif Organs19911442392412060989
   PubMed Web of Science ®Google Scholar
• BruniSChangTMHepatocytes immobilised by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn ratsBiomater Artif Cells Artif Organs19891744034112605354
   PubMed Web of Science ®Google Scholar
• DixitVDarvasiRArthurMBrezinaMLewinKGitnickGRestoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytesHepatology1990126134213492258150
   PubMed Web of Science ®Google Scholar
• WolfFFriedmanEBioartificial Kidneys: Potential Application in Renal Replacement2006Accessed on Mar 10, 2009 Available from: http://www.thedoctorwillseeyounow.com/articles/other/biokid_35/
   Google Scholar
• ChangTMArtificial cells with emphasis on bioencapsulation in biotechnologyBiotechnol Annu Rev199512672959704091
   PubMedGoogle Scholar
• PrakashSChangTMSKinetic studies of microecnapsulated genetically engineered E. coli cells containing K. aerogenes gene for urea and ammonia removalBiotechnol Bioeng19954662162618623357
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMSPrebiotic and probiotic compositions and methodsfor their use in gut-based therapiesWashington DCUS Government Patent #67062872004883887
   Google Scholar
• MalcheskyPSNoseYBiological reactors for renal supportTrans Am Soc Artif Intern Organs197723726729910409
   PubMedGoogle Scholar
• ChangTMSArtificial cell including blood substitutes and 111: from ideas to applicationsArtif Cells Blood Substit Immobil Biotechnol1994225viixiv8055093
   PubMed Web of Science ®Google Scholar
• ChangTMSLiving cells and microorganism immobilized by microencapsulation inside artificial cellsFundamentals of Animal Cell Encapsulation and ImmobilizationNew York, NYCRC Press1992183196
   Google Scholar
• GoosenMFO’SheaGMGharapetianHMChouSSunAMOptimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreasBiotechnol Bioeng198527214615018553649
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMIn vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cellsInt J Artif Organs200023742943510941635
   PubMed Web of Science ®Google Scholar
• ChangTMFuture prospects for artificial bloodTrends Biotechnol1999172616710087605
   PubMed Web of Science ®Google Scholar
• ChangTMPrakashSArtificial cells for bioencapsulation of cells and genetically engineered E. coli. For cell therapy, gene therapy, and removal of urea and ammoniaMethods Mol Biol1997633433589113661
   PubMedGoogle Scholar
• PrakashSJonesMLArtificial cell therapy: New strategies for the therapeutic delivery of live bacteriaJ Biomed Biotechnol200520051445615689638
   PubMedGoogle Scholar
• RossCJRalphMChangPLDelivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsulesHum Gene Ther1999101495910022530
   PubMed Web of Science ®Google Scholar
• ChowKMLiuZCPrakashSChangTMFree and microencapsulated Lactobacillus and effects of metabolic induction on urea removalArtif Cells Blood Substit Immobil Biotechnol200331442543414672417
   PubMed Web of Science ®Google Scholar
• ChangTMSLoaSKUrea removal by urease and ammonia absorbents in the intestineThe Physiologist197013370
   Google Scholar
• PrakashSChangTMMicroencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic ratsArtif Cells Blood Substit Immobil Biotechnol19962432012188773740
   PubMed Web of Science ®Google Scholar
• ChangTMPrakashSTherapeutic uses of microencapsulated genetically engineered cellsMol Med Today1998452212279612802
   PubMedGoogle Scholar
• PrakashSChangTMGrowth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removalArtif Cells Blood Substit Immobil Biotechnol199826135519507755
   PubMed Web of Science ®Google Scholar
• ChangTMArtificial cell biotechnology for medical applicationsBlood Purif2000182919610838466
   PubMed Web of Science ®Google Scholar
• ChangTMPresent status of modified hemoglobin as blood substitutes and oral therapy for end stage renal failure using artificial cells containing genetically engineered cellsAnn N Y Acad Sci200194436237211797686
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMArtificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in vitro and in vivoArtif Cells Blood Substit Immobil Biotechnol200028539740811009112
   PubMed Web of Science ®Google Scholar
• FriedmanEASaltzmanMJBeyerMMJosephsonASCombined oxystarch-charcoal trial in uremia: sorbent-induced reduction in serum cholesterolKidney Int Suppl19767S2732761070546
   PubMed Web of Science ®Google Scholar
• PrakashSChangTMArtificial cell microcapsules containing genetically engineered E. coli DH5 cells for in vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary reportArtif Cells Blood Substit Immobil Biotechnol1999275–647548110595451
   PubMed Web of Science ®Google Scholar
• AebischerPSchluepMDeglonNIntrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patientsNat Med1996266966998640564
   PubMed Web of Science ®Google Scholar
• ChangTMSPrakashSMethods in Molecular Biology: Recombinant Gene Expression ProtocolsNew Jersey NJHumana Press1996343357
   Google Scholar
• PrakashSChangTMGenetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removalBiomater Artif Cells Immobilization Biotechnol19932156296368117852
   PubMed Web of Science ®Google Scholar
• ChangTMSPrakashSMicroencapsulated genetically engineered microrganisms for clinical applicationWashington DCUS Government Patent #62178591997
   Google Scholar
• O’LoughlinJABruderJMLysaghtMJIn vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganismsTissue Eng2004109–101446145515588404
   PubMedGoogle Scholar
• O’LoughlinJABruderJMLysaghtMJDegradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymesASAIO J200450325326015171478
   PubMed Web of Science ®Google Scholar
• FriedmanEAFuture Treatment of Renal Failure: Strategy in renal failureNew York, NYWiley1978521528
   Google Scholar
• DemetriouAAFelcherAMoscioniADHepatocyte transplantation. A potential treatment for liver diseaseDig Dis Sci199136 9132013261893819
   PubMed Web of Science ®Google Scholar
• DemetriouAAWhitingJFFeldmanDReplacement of liver function in rats by transplantation of microcarrier-attached hepatocytesScience19862334769119011922426782
   PubMed Web of Science ®Google Scholar
• GoosenAMMattheusFAResearch on animal cell culture in microcapsulesChem Eng Educ198822196200
   Google Scholar
• SaavedraMJBaumannNOungIPermanJYolkenRHFeeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirusLancet1995344104610497934445
   PubMed Web of Science ®Google Scholar